In this two-part article, the author discusses the New Belgian CFC Rule under Model A of the ATAD. Part 1 deals with the compatibility of Belgium’s implementation of the ATAD’s CFC substance carve-out with EU law and the CJEU’s case law. Part 2, to be published in issue 5 of European Taxation (2026), analyses the case law of other Member States on the application of the substance carve-out under long-standing entity-based CFC rules. The lessons drawn from these cases will be of particular relevance for Belgium and other EU Member States that have more recently adopted entity-based CFC legislation. Two further issues will also be addressed: the interaction between the CFC substance carve-out and the PSD GAAR and the still unexplored question of the elimination of double taxation arising from the application of the CFC rules.
David Seutin (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: